Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab)
产品性质
应用案例
Purity
Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
SEC-HPLC
The purity of Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab) is 98.99%, determined by SEC-HPLC.
ELISA
Immobilized human CD30 His at 2 ug/mL can bind Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab), EC50=0.006007 μg/mL.
存储条件
-25~-15℃保存，有效期1年。
COA
联系我们
